Oncology | Tracking rapid innovation in cancer care

News

AZ piles pressure on MSD et al in gastric cancer

AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage gastric cancer.

News

Magnifying glass held by a human hand over a group of paper people cutouts in different colours

Denying prostate cancer screening 'no longer rational'

A German study has stoked debate about the merits of screening for prostate cancer, which is lagging behind breast cancer screening in Europe.

News

Yellow balloons with smiling faces drawn on them in black ink

J&J says Inlexzo follow-up 'promising' in bladder cancer

Johnson & Johnson says localised delivery of its FGFR inhibitor erdafitinib could provide the first targeted treatment for early‑stage bladder cancer.

News

Immutep investors spooked by LAG-3 failure in lung cancer

Friday the 13th has turned into a horror story for Immutep, whose share price has collapsed after it abandoned a pivotal trial of its LAG-3 drug efti.

News

NICE says no to Genmab cervical cancer therapy

Genmab's recently approved therapy for relapsed cervical cancer has been turned down for NHS use in initial NICE guidance.

News

J&J says Inlexzo follow-up 'promising' in bladder cancer

Johnson & Johnson says localised delivery of its FGFR inhibitor erdafitinib could provide the first targeted treatment for early‑stage bladder cancer.

News

Immutep investors spooked by LAG-3 failure in lung cancer

Friday the 13th has turned into a horror story for Immutep, whose share price has collapsed after it abandoned a pivotal trial of its LAG-3 drug efti.

News

NICE says no to Genmab cervical cancer therapy

Genmab's recently approved therapy for relapsed cervical cancer has been turned down for NHS use in initial NICE guidance.

News

Denying prostate cancer screening 'no longer rational'

A German study has stoked debate about the merits of screening for prostate cancer, which is lagging behind breast cancer screening in Europe.

News

AZ piles pressure on MSD et al in gastric cancer

AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage gastric cancer.

Views & Analysis

Oncology

Day One's big bet on tovorafenib just keeps paying off

Now set to be acquired by Servier for $2.5 billion, Day One Bio proves how far a mission-driven biotech with a strong team and good timing can go.

Oncology

Sponsored

Collaboration & personalisation in rare disease R&D, with AO...

For Rare Disease Day, in an AOP Health-sponsored podcast Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, discussed their work.

Deep Dive

Oncology

City Cancer Challenge: A gender-focused revolution in global...

Oncology

Cell and gene therapies: Stagnation or maturation?

Webinars

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Oncology

Sponsored

How can digital and AI optimise the delivery of patient supp...

How can digital and AI optimise the delivery of patient support programs in cancer?

Oncology

Sponsored

Clinical decision-making insights for haem/oncs

Despite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several decision-making challenges for healthcare professionals.

Oncology

IQVIA_webinar_holding_slide-07.04.20-1200x675-NEW

Sponsored

Unlocking health data to improve oncology outcomes

The NHS’ globally unique health data ecosystem has the potential to improve health outcomes.

Podcasts

Oncology

Sponsored

Collaboration & personalisation in rare disease R&D, with AO...

For Rare Disease Day, in an AOP Health-sponsored podcast Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, discussed their work.

Oncology

pharmaphorum podcast Episode 241, Mohit Manrao, AstraZeneca

On AI and equity in the cancer setting, with Mohit Manrao

Deep Dive editor Eloise McLennan speaks with Mohit Manrao, SVP, head of US oncology at AstraZeneca, and president of the AstraZeneca Foundation.

Oncology

pharmaphorum podcast Episode 238, Andrew Newland, ANGLE

Aligning with national efforts to modernise cancer diagnosti...

Andrew Newland, former CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.

Video

Oncology

A cancer treatment modality that prioritises QoL, with Ben Z...

Immuneering's Ben Zeskind explains how, by focusing on quality of life as well as quantity, they've created a drug for pancreatic cancer.

Oncology

Engineering “smarter” cells, with Tim Lu

Senti Bio's Tim Lu discusses “logic-gated” cells, which have multiple receptors allowing them to attack cancer cells while leaving healthy cells alone

Oncology

Astellas’ banner year and focused R&D strategy, with Adam Pe...

At JPM2026, Astellas' chief strategy officer Adam Pearson walked pharmaphorum through the company’s four-pillared R&D strategy.

White Papers

Oncology

Life Sciences Industry Report - Part 5 feature image

Life Sciences Industry Report - Oncology

Developments in the oncology space in 2024 brought hope to both industry and patients.

Oncology

Sponsored

Patient Centricity to Integration: Enhancing Cancer Outcomes

We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.

White Papers

Sponsored

How pharma can help the post-COVID recovery of European canc...

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians i

Event

Oncology

Partner Content

Tumor Models Summit

The Tumour Models Summit London returns to unite 130+ tumour modelling experts from pharma, biotech, and model providers from across the UK and Europe

Spotlight on

As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content coming to you from onsite in Chicago. We’ll have features and video content rolling out as the presentations unfold day by day.

Spotlight on

ESMO 2025

Spotlight On: ESMO 2025 collates pharmaphorum's coverage of the Congress, including expert insights and interviews.

Oncology

Sponsored

How can digital and AI optimise the delivery of patient supp...

How can digital and AI optimise the delivery of patient support programs in cancer?

Oncology

Sponsored

Meeting MSL training needs in an evolving landscape

As medical treatments become more complex, the role of the Medical Science Liaison (MSL) has never been more important.

Oncology

ZS_webinar_holding_slide-approved_13.09.19

Sponsored

Cost & Management of Oncology Combination Regimens

Overview

Partner Content

Citius Oncology Signs Exclusive Commercialization Agreement ...

Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™

Oncology

Partner Content

Tumor Models Summit

The Tumour Models Summit London returns to unite 130+ tumour modelling experts from pharma, biotech, and model providers from across the UK and Europe

Oncology

Partner Content

3rd Cell Therapy for Autoimmune Disease Summit

Over the past year autoimmune cell therapies has seen billion-dollar investments, consistent innovation, and success stories

AZ piles pressure on MSD et al in gastric cancer

Denying prostate cancer screening 'no longer rational'

J&J says Inlexzo follow-up 'promising' in bladder cancer

Immutep investors spooked by LAG-3 failure in lung cancer

NICE says no to Genmab cervical cancer therapy

J&J says Inlexzo follow-up 'promising' in bladder cancer

Immutep investors spooked by LAG-3 failure in lung cancer

NICE says no to Genmab cervical cancer therapy

Denying prostate cancer screening 'no longer rational'

AZ piles pressure on MSD et al in gastric cancer

Day One's big bet on tovorafenib just keeps paying off

Collaboration & personalisation in rare disease R&D, with AO...

City Cancer Challenge: A gender-focused revolution in global...

Cell and gene therapies: Stagnation or maturation?

How can digital and AI optimise the delivery of patient supp...

Clinical decision-making insights for haem/oncs

Unlocking health data to improve oncology outcomes

Collaboration & personalisation in rare disease R&D, with AO...

On AI and equity in the cancer setting, with Mohit Manrao

Aligning with national efforts to modernise cancer diagnosti...

A cancer treatment modality that prioritises QoL, with Ben Z...

Engineering “smarter” cells, with Tim Lu

Astellas’ banner year and focused R&D strategy, with Adam Pe...

Life Sciences Industry Report - Oncology

Patient Centricity to Integration: Enhancing Cancer Outcomes

How pharma can help the post-COVID recovery of European canc...

Tumor Models Summit

ASCO 2025

ESMO 2025

How can digital and AI optimise the delivery of patient supp...

Meeting MSL training needs in an evolving landscape

Cost & Management of Oncology Combination Regimens

Citius Oncology Signs Exclusive Commercialization Agreement ...

Tumor Models Summit

3rd Cell Therapy for Autoimmune Disease Summit

Basecamp lifts veil on Trillion Gene Atlas genomics push

Using AI-driven synthetic personas to take your insights fur...

News

Views & Analysis

Deep Dive

Editor's Picks

Webinars

Podcasts

Video

White Papers

Event

Debates & Insight

Partner Content

Editor's Picks